Maria Lagadinou

1.0k total citations
57 papers, 692 citations indexed

About

Maria Lagadinou is a scholar working on Infectious Diseases, Epidemiology and Neurology. According to data from OpenAlex, Maria Lagadinou has authored 57 papers receiving a total of 692 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Infectious Diseases, 18 papers in Epidemiology and 9 papers in Neurology. Recurrent topics in Maria Lagadinou's work include COVID-19 Clinical Research Studies (15 papers), Long-Term Effects of COVID-19 (9 papers) and SARS-CoV-2 and COVID-19 Research (8 papers). Maria Lagadinou is often cited by papers focused on COVID-19 Clinical Research Studies (15 papers), Long-Term Effects of COVID-19 (9 papers) and SARS-CoV-2 and COVID-19 Research (8 papers). Maria Lagadinou collaborates with scholars based in Greece, United States and United Kingdom. Maria Lagadinou's co-authors include Markos Marangos, Dimitrios Velissaris, Stelios F. Assimakopoulos, Nicholas Zareifopoulos, Despοina Gkentzi, Vasileios Karamouzos, Charalambos Gogos, George Panos, Dimitrios Velissaris and Elena E. Solomou and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Frontiers in Microbiology.

In The Last Decade

Maria Lagadinou

56 papers receiving 672 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maria Lagadinou Greece 16 215 202 90 80 79 57 692
Navaneeth Narayanan United States 14 219 1.0× 286 1.4× 93 1.0× 50 0.6× 71 0.9× 47 659
Silvia Spoto Italy 17 340 1.6× 234 1.2× 61 0.7× 120 1.5× 102 1.3× 72 867
Simone Mornese Pinna Italy 12 142 0.7× 223 1.1× 48 0.5× 49 0.6× 40 0.5× 46 589
Florian Hitzenbichler Germany 18 212 1.0× 412 2.0× 108 1.2× 62 0.8× 79 1.0× 63 833
A Muzzi Italy 13 287 1.3× 178 0.9× 48 0.5× 26 0.3× 116 1.5× 44 763
Noriko Kinoshita Japan 18 317 1.5× 346 1.7× 85 0.9× 128 1.6× 126 1.6× 71 1.1k
Yu. V. Lobzin Russia 10 237 1.1× 194 1.0× 72 0.8× 40 0.5× 71 0.9× 99 593
Diamantis P. Kofteridis Greece 16 262 1.2× 297 1.5× 71 0.8× 51 0.6× 121 1.5× 60 1.0k
Andrea Marıno Italy 19 301 1.4× 250 1.2× 37 0.4× 48 0.6× 81 1.0× 89 953
Kensuke Shoji Japan 16 377 1.8× 352 1.7× 47 0.5× 37 0.5× 28 0.4× 109 824

Countries citing papers authored by Maria Lagadinou

Since Specialization
Citations

This map shows the geographic impact of Maria Lagadinou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Lagadinou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Lagadinou more than expected).

Fields of papers citing papers by Maria Lagadinou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Lagadinou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Lagadinou. The network helps show where Maria Lagadinou may publish in the future.

Co-authorship network of co-authors of Maria Lagadinou

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Lagadinou. A scholar is included among the top collaborators of Maria Lagadinou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Lagadinou. Maria Lagadinou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lagadinou, Maria, Anastasia Spiliopoulou, Fevronia Kolonitsiou, et al.. (2025). Impact of the COVID-19 pandemic on vancomycin-resistant Enterococcus bloodstream infections: a 6-year study in Western Greece. Frontiers in Microbiology. 16. 1656334–1656334.
2.
Αγγελετοπούλου, Ιωάννα, et al.. (2024). Diagnostic and Prognostic Ability of Pancreatic Stone Protein: A Scoping Review. International Journal of Molecular Sciences. 25(11). 6046–6046. 4 indexed citations
3.
4.
Lagadinou, Maria, et al.. (2023). Presepsin in the diagnosis of sepsis. Clinica Chimica Acta. 550. 117588–117588. 16 indexed citations
5.
6.
Marangos, Markos, et al.. (2023). Oral Antibiotics for Bacteremia and Infective Endocarditis: Current Evidence and Future Perspectives. Microorganisms. 11(12). 3004–3004. 3 indexed citations
7.
Ακρίδα, Ιωάννα, et al.. (2023). An Updated Review on the Emerging Role of Indocyanine Green (ICG) as a Sentinel Lymph Node Tracer in Breast Cancer. Cancers. 15(24). 5755–5755. 20 indexed citations
8.
Lagadinou, Maria, et al.. (2022). The Role of High Flow Nasal Oxygen in the Management of Severe COVID-19: A Systematic Review. Acta Médica Portuguesa. 35(6). 476–483. 3 indexed citations
9.
Assimakopoulos, Stelios F., et al.. (2022). SARS CoV-2-Induced Viral Sepsis: The Role of Gut Barrier Dysfunction. Microorganisms. 10(5). 1050–1050. 28 indexed citations
10.
Karampitsakos, Τheodoros, Ουρανία Παπαϊωάννου, Andreas P. Kalogeropoulos, et al.. (2022). Tocilizumab versus baricitinib in hospitalized patients with severe COVID-19: an open label, randomized controlled trial. Clinical Microbiology and Infection. 29(3). 372–378. 26 indexed citations
11.
Karimabad, Mojgan Noroozi, Gholamhossein Hassanshahi, Nicholas G. Kounis, et al.. (2022). The Chemokines CXC, CC and C in the Pathogenesis of COVID-19 Disease and as Surrogates of Vaccine-Induced Innate and Adaptive Protective Responses. Vaccines. 10(8). 1299–1299. 4 indexed citations
12.
Lagadinou, Maria, et al.. (2022). Alterations in neutrophil to lymphocyte ratio: An inexpensive, reproducible prognostic marker in patients with complicated liver cirrhosis. Journal of Clinical Images and Medical Case Reports. 3(4). 1 indexed citations
13.
Lagadinou, Maria, et al.. (2022). Alterations in Laboratory Parameters Related to Disease Severity in Vaccinated Patients Against SARS-CoV-2. Journal of Clinical Medicine Research. 14(11). 487–491. 1 indexed citations
14.
Lagadinou, Maria, et al.. (2021). Vitamin D plasma levels in patients with COVID-19: a case series.. PubMed. 29(2). 224–228. 4 indexed citations
15.
Zareifopoulos, Nicholas, et al.. (2021). Correlation of Positive Blood Cultures with Peripherally Inserted Central Catheter Line Infection in Oncology Patients. Cureus. 13(1). e12858–e12858. 3 indexed citations
16.
Tsiganos, Panagiotis, Foteinos‐Ioannis Dimitrakopoulos, Maria Tolia, et al.. (2021). Radiotherapy and Renal Cell Carcinoma: A Continuing Saga. In Vivo. 35(3). 1365–1377. 6 indexed citations
17.
Zareifopoulos, Nicholas, et al.. (2020). Intubation and mechanical ventilation of patients with COVID-19: what should we tell them?. SHILAP Revista de lepidopterología. 90(1). 22 indexed citations
18.
Zareifopoulos, Nicholas, et al.. (2020). Management of COVID-19: the risks associated with treatment are clear, but the benefits remain uncertain. SHILAP Revista de lepidopterología. 90(2). 4 indexed citations
19.
Lagadinou, Maria, Virginia Mplani, Dimitrios Velissaris, Periklis Davlouros, & Markos Marangos. (2019). Myocarditis Caused by Brucella melitensis in the Absence of Endocarditis: Case Report and Review of the Literature. Case Reports in Medicine. 2019. 1–4. 8 indexed citations
20.
Velissaris, Dimitrios, Vasileios Karamouzos, Maria Lagadinou, Charalampos Pierrakos, & Markos Marangos. (2019). Peripheral Inserted Central Catheter Use and Related Infections in Clinical Practice: A Literature Update. Journal of Clinical Medicine Research. 11(4). 237–246. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Navaneeth Narayanan Breakdown of academic impact, for papers by Silvia Spoto Breakdown of academic impact, for papers by Simone Mornese Pinna Breakdown of academic impact, for papers by Florian Hitzenbichler Breakdown of academic impact, for papers by A Muzzi Breakdown of academic impact, for papers by Noriko Kinoshita Breakdown of academic impact, for papers by Yu. V. Lobzin Breakdown of academic impact, for papers by Diamantis P. Kofteridis Breakdown of academic impact, for papers by Andrea Marıno Breakdown of academic impact, for papers by Kensuke Shoji
Rankless by CCL
2026